Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Gyre Therapeutics (GYRE) Inventory Average (2024 - 2025)

Historic Inventory Average for Gyre Therapeutics (GYRE) over the last 3 years, with Q3 2025 value amounting to $8.9 million.

  • Gyre Therapeutics' Inventory Average rose 4745.3% to $8.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.9 million, marking a year-over-year increase of 4745.3%. This contributed to the annual value of $5.3 million for FY2024, which is 206.67% up from last year.
  • Per Gyre Therapeutics' latest filing, its Inventory Average stood at $8.9 million for Q3 2025, which was up 4745.3% from $8.4 million recorded in Q2 2025.
  • Gyre Therapeutics' 5-year Inventory Average high stood at $8.9 million for Q3 2025, and its period low was $4.6 million during Q1 2024.